Introduction
The microtubule network has fundamental roles in cell structure and function and, as such, is commonly altered in pathology from neoplasia to neurological disorders. 1 Key in the organization of this network in animal cells is the centrosome, an organelle that provides support to and regulation of diverse biological processes, including the formation of mitotic spindles and cilia, and progression through cytokinesis. 2 In recent years, proteins with the conserved transforming acidic coiled-coil (TACC) domain have emerged as important players in centrosome biology, initially described in Drosophila as necessary for centrosome activity and microtubule assembly during cell division. 3, 4 Knowledge of the role of TACCs in microtubule dynamics and centrosome biology comes predominantly from observations of a conserved protein interaction across species, or interolog, 5 with ch-TOG/CKAP5
TACC3-TSC2 maintains nuclear envelope structure and controls cell division and their regulation by aurora kinase A (AURKA) (reviewed in refs. [6] [7] [8] [9] . Studies in human cells and model organisms have revealed a key role of TACC3 in centrosome-dependent microtubule assembly, kinetochore attachment and chromosome alignment during mitosis. [10] [11] [12] [13] [14] In addition, a recent study 15 described a link between TACC3 and regulation of mitotic exit through the activator of the anaphase promoting complex/cyclosome, FZR1/CDH1, which further supports an important role in cell division.
Inactivating mutations in the tumor suppressor genes TSC1 and TSC2 cause TSC syndrome 16, 17 and sporadic pulmonary LAM disease. 18, 19 TSC is characterized by the presence of hamartomas, which consist of benign dysplastic and disorganized overgrowth within many organs and tissues. 20 TSC patients can also develop neurological abnormalities such as seizures, mental retardation and autism, in addition to renal cysts (reviewed in ref. 20 
). On
Studies of the role of tuberous sclerosis complex (tSC) proteins (tSC1/tSC2) in pathology have focused mainly on their capacity to regulate translation and cell growth, but their relationship with alterations of cellular structures and the cell cycle is not yet fully understood. the transforming acidic coiled-coil (tACC) domain-containing proteins are central players in structures and processes connected to the centrosome. Here, tACC3 interactome mapping identified tSC2 and 15 other physical interactors, including the evolutionary conserved interactions with ch-toG/CKAp5 and FAM161B. tACC3 and tSC2 co-localize and co-purify with components of the nuclear envelope, and their deficiency causes morphological alterations of this structure. During cell division, tACC3 is necessary for the proper localization of phospho-Ser939 tSC2 at spindle poles and cytokinetic bridges. Accordingly, abscission alterations and increased frequency of binucleated cells were observed in tacc3-and tsc2-deficient cells relative to controls. In regulating cell division, TSC2 acts epistatically to TACC3 and, in addition to canonical tSC/mtoR signaling and cytokinetic associations, converges to the early mitotic checkpoint mediated by CHFR, consistently with nuclear envelope associations. our findings link tACC3 to novel structural and cell division functions of tSC2, which may provide additional explanations for the clinical and pathological manifestations of lymphangioleiomyomatosis (LAM) disease and tSC syndrome, including the greater clinical severity of TSC2 mutations compared to TSC1 mutations.
C-terminal region of the corresponding proteins (Fig. 1A and Suppl. Material, Fig. S1 ). A range of molecular and functional evidence, including co-affinity purification (co-AP) and endogenous co-immunoprecipitation (co-IPs) assays, supports the high-confidence of this interactome. First, two interologs were identified: with ch-TOG/CKAP5, conserved interaction with TACC ortholog in S. pombe, C. elegans (TAC-1), D. melanogaster and X. leavis; 6 and with FAM161B, conserved interaction with TAC-1 (FAM161B putative ortholog: Y38H6C.14, hypothetical protein NP_507957). 51 In addition, KIF1C, another newly identified physical interactor of TACC3, has a homolog (KLP-1) at "two-hop" interactions of TAC-1 (Fig. 1A) , which further suggests the identification of an evolutionary conserved TACC interaction module.
The fact that no additional interologs were detected-in particular relative to TAC-1, which essentially contains the TACC domain-may be due to technical limitations and/or evolutionary differences. Phylogenetic analysis indicated that human TACCs probably resulted from two consecutive duplications occurring after the divergence of vertebrates and uro-chordates, and that TACC1 and 2 originated from the most recent of these duplications and are, therefore, more evolutionarily related to each other than to TACC3 (Suppl. Material, Fig. S2) . 52 This analysis also suggested accelerated evolution of TACCs among coiled-coil domain-containing proteins, which may further explain interactome differences across species (Suppl. Material, Fig. S3 ).
The similarity of gene expression profiles, measured with the Pearson correlation coefficient (PCC) across a large number of normal human samples, 53 for 7 of the 12 TACC3-Y2H prey gene pairs is further evidence of the high-confidence of the interactome ( Fig. 1A ; |PCC|>0.30, Bonferroni-corrected p values <0.05). The primary area of similarity was positive co-expression, which suggests synergistic roles in centrosome biology. Finally, analysis of Gene Ontology (GO) term annotations in the TACC3 interactome relative to all human coding genes identified significant over-representation of microtubule-associated biological processes (Suppl. Material, Table S1), which include important regulators of cilia formation (CEP164 49 and CP110 50 ) and cytokinesis (ARHGEF2/GEF-H1,  54 LAPSER1/LZTS2  55 and TACC1  56 ) . The TACC3 interactions identified in the Y2H system were further evaluated in complementary or independent biochemical assays. The interaction with IPORIN/RUSC2 was narrowed down to the RUN domain using a series of mutants in a different Y2H system and by co-AP, and the interactions with CP110 and KIF1C were corroborated by GST-TACC3 co-APs (Suppl. Material, Fig. S4 ). Additionally, co-IPs in HEK293 cell extracts identified complexes between TACC3 and ARHGEF2/ GEF-H1, CGN, CP110 (Suppl. Material, Fig. S5 ) or TSC2 (Fig.  1B) . ARHGEF2 and CGN were previously shown to interact physically, 57 which further supports the detection of true positive interactions for TACC3. The interaction between TACC3 and TSC2 was detected reciprocally using different subconfluent and unsynchronized cell cultures and specific antibodies in co-IP assays (Fig. 1B and subsequent sections) : however, unlike endogenous levels of TSC2, TACC3-TSC2 complex formation is likely to be condition/location-dependent or transient. Protein average, greater disease severity has been associated with TSC2 mutations for multiple clinical features including neurological abnormalities and the development of renal cysts. 21, 22 Therefore, possible specificities between TSC1/TSC1 and TSC2/TSC2 may provide a more detailed understanding of pathological manifestations of TSC and LAM.
Hamartin and tuberin, the respective products of TSC1 and TSC2, form a heterodimer that inhibits the rapamycin-sensitive mammalian target of rapamycin (mTOR)/raptor complex (mTORC1). [23] [24] [25] [26] [27] [28] mTORC1 positively regulates protein synthesis and cell growth by integrating mitogenic signals and nutrient availability via substrates including p70 S6 kinase (S6K/ RPS6KB1/RPS6KB2) and 4E-BP1/EIF4EBP1. [29] [30] [31] [32] [33] TSC proteins have also been implicated in regulation of the cell cycle through the cyclin-dependent kinase inhibitor p27
Kip1 /CDKN1B, possibly linked to the development of different types of neoplasms. [34] [35] [36] [37] In addition, the TSC1-TSC2 complex activates the rapamycininsensitive mTOR/rictor complex (mTORC2), 38 which regulates the actin cytoskeleton 39, 40 and AKT phosphorylation. [41] [42] [43] [44] Recently, a role for TSC proteins in the biology of centrosomes and basal body of cilia has been described through complementary approaches: TSC1 interacts with the mitotic regulator PLK1 in a phosphorylation-dependent manner and is necessary for proper maintenance of centrosome number; 45 and genetic and molecular interactions between the TSC1/TSC1-TSC2/TSC2 and PKD1/ PKD1 (polycystin 1) are implicated in cilia formation. [46] [47] [48] Here, TACC3 interactome mapping identified physical interactions with 16 different proteins, including TSC2 and additional regulators of cilia formation, CEP164, 49 and CP110. 50 In interphase, Tacc3 and Tsc2, but not Tsc1, co-localize and coimmunoprecipitate with components of the nuclear envelope and their deficiency causes alterations of this structure. During cell division, TACC3 is necessary for proper localization of phosphoSer939 (pS939) TSC2 to the mitotic apparatus and cytokinetic structures. Consistently, aberrant cytokinetic abscission and increased frequency of binucleated cells were observed in Tacc3-and Tsc2-deficient cell cultures. Moreover, in agreement with critical gene/protein relationships at different phases of the cell cycle, TSC2 acts epistatically to TACC3 in regulating cell viability. According to their participation in the maintenance of the nuclear envelope structure, this genetic interaction inhibited the early mitotic checkpoint mediated by the checkpoint with forkhead and ring finger domains (CHFR) protein. Taken together, our results link TACC3/TACC3 to novel structural and cell division functions of TSC2/TSC2, which may provide complementary explanations for some of the clinical manifestations of TSC and LAM.
Results
A high-confidence TACC3 interactome network linked to centrosome biology. To investigate TACC3 function, we screened for physically interacting proteins using the yeast two-hybrid (Y2H) system. Sixteen different and mostly novel interactions were identified with the TACC domain as bait, including the TACC3 homodimer and TACC1 and TACC2 heterodimers through the TACC3-TSC2 localize to the nuclear envelope and their depletion causes morphological alterations of this structure. The identification of the tumor suppressor TSC2 as a novel TACC3 interactor supports its involvement in microtubuledependent structures and processes. [59] [60] [61] An in vitro microtubule-binding assay using taxol and nocodazole for microtubule stabilization and depolymerization, respectively, and polo-like kinase 1 (PLK1) and α-tubulin (TUBA) as controls, showed that fractions of TSC2 and its heterodimeric partner TSC1 are associated with microtubules ( Fig. 2A) . This finding may be linked to previous work indicating a role of TSC2/mTOR in regulation of microtubule organization. 61 To further investigate the association of TSC2 with cellular structures, we examined its subcellular localization in HeLa cells and murine embryonic fibroblast (MEF) cultures derived from littermate embryos with the Tsc2 -/-/ Tp53 -/-genotype or from controls with the Tsc2 +/+ /Tp53 -/-genotype. These analyses suggested localization of TSC2/Tsc2 at complexes of TACC3-TSC2 were identified in HEK293 and MCF7 extracts (Fig. 1B) , and in cell cycle-synchronized HeLa extracts (subsequent sections). In addition, complexes of TACC3 and pS939-TSC2 were detected in BT474 extracts (Fig. 1B) , which are known to contain abundant phosphorylated TSC2 as compared to MCF7. 58 To identify the TACC3-binding domain in TSC2, co-AP assays with predefined TSC2 fragments 59 suggested that the N-terminal region (amino acids (aa) 1-460) but not the rest of the protein (data not shown) mediates the interaction (Fig. 1C) . This TSC2 fragment contains the TSC1-binding domain and a coiled-coil motif (TSC2 hamartin-binding domain; TSC2-HBD) and, in agreement with the TACC3 interactome, was shown to be involved in the regulation of the cytoskeleton and cell adhesion. 59, 60 Together, these observations delineate a high-confidence TACC3 interactome network which includes TSC2 and is linked to centrosome biology. TACC3 in HeLa cells was used. 13 Depletion of TACC3 in HeLa cells correlated with loss of reactivity of pS939-TSC2 at spindle poles and intercellular bridges during cytokinesis (Fig. 4A) . Phosphorylated mTOR has been previously described to localize to mitotic and cytokinetic structures. 68, 69 However, in contrast to pS939-TSC2, we did not observe alterations of pS2448-mTOR in TACC3-depleted HeLa cells (Suppl. Material, Fig. S8 ), which further supports a specific function of TSC2 in relation to TACC3 during cell division.
Tacc3 or Tsc2 deficiency results in cytokinetic delay and formation of binucleated cells. Consistent with loss of pS939-TSC2 localization to cytokinetic structures in TACC3-depleted cells, abnormally elongated abscission was a common phenotype observed in unsynchronized Tacc3-and Tsc2-deficient MEFs detected using aurora kinase B (Aurkb) immunostaining (Fig.  4B) . In addition, higher percentages of binucleated cells were observed in Tacc3 +/+ /Tp53 -/-3.3 ± 1.7%; these percentages illustrate the results of a typical experiment of three replicates with >400 cells counted each). These results suggest a role for TACC3 and TSC2 in regulating cytokinesis, and are consistent with previously reported tetraploidization of Eker rat-derived cell cultures with a germline Tsc2 mutation. 70 Next, Eker rat leiomyoma tumor cells (ELT3) were used to evaluate the effects of Tsc2-defiency on cell division in synchronized cultures. Tsc2-deficient ELT3 cells exhibited significant delay in completion of cytokinesis relative to human TSC2 (hTSC2)-reconstituted cells (Fig. 4C shows a typical experiment with total >500 cells counted at each time-point; twotailed t-test at 90 minutes (min) p = 0.005; and Suppl. Material, Fig. S9) . Surprisingly, slower completion of cytokinesis after nocodazole release was also observed in Tsc1-deficient compared to human TSC1 (hTSC1)-reconstituted MEFs (Suppl. Material, Fig. S10 ) and, consistently, Tsc1-deficient cells also showed increased incidence of binucleated cells after nocodazole release relative to wildtype cells (Suppl. Material, Fig. S11 ). However, aberrant cytokinetic figures (i.e., elongated abscission) were not observed at an increased frequency in Tsc1-deficient cells (Suppl. Material, Fig. S11 ), which suggest complementary but not fully redundant functions of TSC1 and TSC2 in cell division, with TACC3-mediated localization of pS939-TSC2 at cytokinetic structures.
If they are biologically relevant in vivo, the cytokinetic abnormalities observed in ELT3 cell cultures should correlate with detectable alterations of gene expression in epithelial tissues of Eker rats compared to controls. To test this hypothesis, we evaluated association of cell cycle-related gene sets (i.e., sets for G 1 /S, S, G 2 , G 2 /M and M/G 1 phases 71 ) in a genome-wide expression dataset of Eker rat kidneys and controls 72 using the non-parametric approach in the Gene Set Enrichment Analysis (GSEA) tool. 73 This analysis revealed that Eker rat kidneys, compared to normal rat kidneys, had higher expression of genes involved in cytokinesis and mitotic exit (M/G 1 set, p = 0.04 , Fig. 4D) ; however, other cell cycle-related gene sets were not different (p > 0.20). This the nuclear envelope in interphase cells (Fig. 2B) . In support of this hypothesis, TSC2 co-IPs with the nuclear pore subunit NUP62 (Fig. 2C) , which in turn interacts physically with centrosome-and nuclear envelope-associated proteins. 62 In addition, TACC3 was also found to localize at the nuclear envelope (Suppl. Material, Fig. S6 ) and, importantly, TAC-1 was previously found to interact physically with components of the nuclear pore (NPP-1) and lamina (LMN-1). 63 Moreover, using subcellular fractionation, Tsc2 and Tacc3, but not Tsc1, co-purified with the major structural component of the inner nuclear membrane, lamin A (Lmna) (Fig. 2D) .
Perturbation of centrosome and/or nuclear envelope proteins may cause morphological alterations of the envelope structure. [64] [65] [66] In addition, taxol treatment of cell cultures causes dramatic unraveling of the nuclear lamina and disorganization of nuclear pore structures. 67 Consistent with their localization, morphological alterations of the envelope in Tacc3-and Tsc2-but not Tsc1-deficient MEFs were detected using Nup62 immunostaining ( Fig. 2E shows representative fluorescence microscopy images of Tacc3-and Tsc2-deficient MEFs and controls). Tacc3-deficient MEFs also showed micronuclei figures at a frequency of 4.6 ± 1.5%, which were barely observed in wildtype (WT) MEFs similarly immortalized (0.3 ± 0.5%; these results correspond to a typical experiment of four replicates with >200 cells counted each) (Fig. 2E) . However, micronuclei figures were not observed in Tsc2-and Tsc1-deficient MEFs (data not shown). Taken together, these results suggest a specific role of TSC2 in maintaining proper nuclear envelope structure, possibly involving TACC3.
pS939-TSC2 localizes to spindle poles and cytokinetic structures in a TACC3-dependent manner. Given the physical interaction between TACC3 and TSC2, and the key role of TACC3 in regulation of cell division, [10] [11] [12] [13] [14] we next analyzed the subcellular localization of TACC3 and TSC2 (total and pS939) during mitosis by confocal laser scanning microscopy in four cell lines (BT474, HeLa, MCF7 and MCF10A). In metaphase, TACC3 and total-TSC2 localized at the spindle microtubules and poles, while pS939-TSC2 was specifically detected at the poles (Fig. 3A and Suppl. Material, Fig. S7 ). In telophase and cytokinesis, both total-and pS939-TSC2 were particularly strong at the cleavage furrow, while TACC3 localized in the pericentrosomal region and at the remaining polar spindle microtubules in the midbody (Fig. 3B) . Given the observed interaction through TSC2-HBD (Fig. 1C) , these observations suggest dynamic associations between TACC3, TSC1 and TSC2. Accordingly, using HeLa cultures synchronized by a double-thymidine block and PLK1 as mitotic marker, TACC3-TSC2 complexes were mostly evident through mitosis (4-10 hours (h) after release), while TSC1-TSC2 complexes appeared more strongly in S-G 2 /M (2 and 4 h after release) (Fig. 3C) . Taken together, these data are consistent with co-IP results in unsynchronized cell cultures (Fig. 1B) and suggest a role for TACC3-TSC2 in regulation of cell division.
Having established a dynamic association between TACC3 and TSC2, we next evaluated the dependence on TACC3 for TSC2 localization during cell division. A doxycycline (DOX)-regulated shRNA system allowing almost complete depletion of TACC3 rescued the reduced viability observed in the TACC3-depleted cells to a level similar to that observed in the presence of TSC2 depletion only (Bonferroni-corrected p = 0.09). Taken together, these data suggest that TSC2 acts epistatically to TACC3 in regulation of cell viability.
Sensing the integrity of the microtubule network and the nuclear envelope structure contributes to an early mitotic checkpoint mediated by CHFR, 74, 75 which is a regulator of AURKA.
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In keeping with a putative role of TACC3 and TSC2 in microtubule dynamics and nuclear envelope structure (Fig. 2) , levels of CHFR and cyclin B1 (CCNB1) were higher in MCF7 cells after shRNA-mediated depletion of either TSC2 or TACC3 (Fig.  5B) . Accumulation of CCNB1 is consistent with previous observations of cell cycle-dependent regulation and depletion studies of TACC3 expression. [13] [14] [15] However, simultaneous depletion of observation further supports the critical role of TSC2/Tsc2 in cytokinesis and suggests relevant consequences in pathology. TSC2 acts epistatically to TACC3 in the control of cell viability. To decipher the underlying TACC3-TSC2 relationship in control of cell division, we examined the existence of genetic interactions. Lentiviral shRNA constructs were transduced into MCF7 cells, and the effects of single gene depletions were compared to those of simultaneous depletion of TACC3 and TSC2 in a cell viability assay (time course of viable cells measured using a methylthiazol tetrazolium (MTT) assay). Depletion of TSC2 significantly increased viability relative to the pLKO.1 control, whereas loss of TACC3 had the opposite effect (Fig. 5A , the graph shows the typical results of three independent experiments in MCF7 cultures; ANCOVA Bonferroni-corrected p values <0.005). Interestingly, simultaneous depletion of TSC2 and in an increase in phosphorylation of ribosomal protein S6 kinase (pT389-S6K), as expected, TACC3-depleted cells showed lower levels of this marker (Fig. 5B) . Consistent with an epistatic relationship, simultaneous depletion of both proteins resulted in increased pT389-S6K (Fig. 5B) . To determine whether aberrant mTOR signaling in Tsc2-deficient cells leads to perturbation of Tacc3 expression, protein levels were assayed in rapamycin-treated Tsc2-deficient MEFs and ELT3 cells and compared to DMSO-treated controls. These assays revealed that inhibition of mTOR signaling significantly inclreases Tacc3 levels (Fig. 5C) . Together, these observations support the convergence of TACC3/TACC3 and TSC2/TSC2 in nuclear envelope structure integrity and cell division control through genetic and molecular interactions.
Discussion
In this study, we describe the participation of TSC2/TSC2 in maintaining proper nuclear envelope structure and controlling different phases of cell division possibly through genetic and molecular interactions with TACC3/TACC3. Three important, interconnected insights can be derived from our results. First, while the novel TACC3 physical interactions are consistent with known molecular and functional associations of TACCs across species, 6 they also provide novel mechanistic hypotheses on the role of TACCs in microtubule-network organization and centrosome or basal body biology. Since TACCs are deregulated in many epithelial neoplasias, 8 TACC3 may be involved in cell migration and differentiation through its interaction with ARHGEF2 (also known as GEF-H1/Lfc) and CGN, both corroborated by co-IP assays. ARHGEF2 is a guanine nucleotide exchange factor for RhoA and CGN is a cell-to-cell tight junction adaptor. 77 ,78 CGN binding to ARHGEF2 inhibits RhoA activation, promoting polarized epithelial formation. 57 The role of TACCs in this process is unknown but TSC1/TSC2 has been shown to regulate Rho GTPases. 59, 60, 79 This function of TSC proteins may explain TSC2 and TACC3 did not cause an accumulation of CHFR or CCNB1 (Fig. 5B) , which is consistent with an epistatic relationship (Fig. 5A) . Accumulation of CHFR/CCNB1 and activation of the early mitotic checkpoint in TSC2-depleted cells may be compatible with increased proliferation due to the concomitant increase in mTOR signaling and translation. While TSC2 depletion resulted events by TACC3/TACC3-TSC2/TSC2. Our data suggest that when cell division begins, CHFR senses the structure of the nuclear envelope and probably that of the microtubule network 74,75 through a mechanism involving TACC3 and TSC2. Next, TACC3 regulates pS939-TSC2 localization, possibly linked to the cytokinetic abnormalities observed in Tacc3-and Tsc2-deficient MEFs. Our study also suggests that TSC1 may have a complementary role in cytokinesis, although this might be independent of TACC3, as indicated by the implication of the phosphorylated TSC2 form commonly believed to be "inactive" (pS939). Our results showing increased frequency of binucleated cells are consistent with a previous study in which tetraploidization was observed in smooth muscle cells derived from Eker rats with a Tsc2 germline mutation 70 and with altered M/G 1 genes expression in the Eker kidney. Together, this study provides evidence of novel interactions and functions for TACC3/TACC3 and TSC2/TSC2 possibly linked to centrosome biology and TSC/LAM pathology.
Materials and Methods
Y2H screens. Y2H screens were performed following two different strategies, transformation and mating, 89 and using two different cDNA libraries, of human fetal brain and spleen (ProQuest, Invitrogen). Three TACC3 baits were defined according to protein domains, 3, 52, 90 with the C-term region spanning amino acids aa 629-838. The Gateway system (Invitrogen) was used for cloning and, subsequently, baits were fully sequenced so that they did not show changes relative to publicly available sequence information. Products were transferred to the pPC97 yeast expression vector (Invitrogen) and then transformed in MaV203 (Invitrogen) or AH109 (Clontech) yeast strains for screens using selective medium lacking histidine and supplemented with 10 mM (mating protocol) or 20 mM (transformation protocol) 3-amino-triazole (3-AT, Sigma-Aldrich) to test the interaction-dependent transactivation of the HIS3 reporter. Previously, baits were examined for self-activation at 3-AT range concentrations in the range 10-80 mM. Together, using these conditions, more than 10 million transformants were screened for each bait. Positive colonies were grown in selective medium for three cycles (10-15 days) to avoid unspecific cDNA contaminants, prior to PCR amplification and sequence identification of preys. 91 To map the IPORIN/RUSC2 interaction domain, 92 the TACC3 C-term was transferred to the pAS2-1 vector to test the interaction-dependent transactivation of the lacZ reporter.
Microarray data analysis. The similarity of expression profiles was evaluated by computing PCCs using normalized (gcRMA) expression levels from the GeneAtlas U133A human dataset. 53 Comparisons were made for all possible microarray probe pairs and p values adjusted for multiple testing using the Bonferroni approach. Enrichment in GO term annotations was computed using the Onto-Express tool 93 with all coding human genes as reference. The GSEA 73 was run using the Gene Expression Omnibus reference GSE5923, 72 with default values for all the parameters except for the median probe instead of the max probe as the collapse method when multiple probe sets map to the same gene. the metastatic phenotype of benign smooth muscle-like cells in lymphangiomyomatosis (LAM) caused by TSC2 mutations (reviewed in ref. 80 ). Binding of TSC2 to TSC1 causes activation of RAC1 and, consequently, inhibition of RhoA activity. 59 Since TACC3 might interact with TSC2 through the TSC2-HBD domain, it could have a role in promoting cytoskeletal remodeling and the metastatic LAM phenotype. Alternatively, RhoA and the actin cytoskeleton can be potentially regulated by the TACC3-TSC2-mTORC2 axis. 39, 40 Similar regulation may also occur during cell division. ARHGEF2, once it has been released from its phospho-dependent inhibition by AURKA, activates RhoA to promote cytokinesis. 54 ARHGEF2 and TSC2 may then compete for TACC3 binding in a similar manner to the transition from epithelial proliferation to differentiation. The role of TACC3 in these processes may be common or converge on other TACCs, as our data suggest heterodimer formations.
Closely related to the process mediating epithelial polarity, the TACC3 interactome may also provide additional hypotheses on the development of renal cysts in TSC patients. Renal cysts appear more frequently in patients with TSC2 mutations. 21, 22 Tsc1 and Tsc2-deficent MEFs show enhanced primary cilium development, and the corresponding genes interact with Pkd1 in this process. 46, 47 As corroborated by co-AP and co-IP assays, the physical interaction of TACC3 with key players in primary cilium development, where CEP164 is a promoter 49 and CP110 a suppressor, 50, 81 suggests that TSC2 function in this process can be mediated through regulation of these interactions. Similarly to processes of epithelial polarity and mitotic exit, inactivation of AURKA, the master regulator of TACCs, is necessary for cilium formation, 82 which in turn might be coordinated with regulation of the novel TACC3 interactions with TSC2 and CEP164/CP110.
The second insight that can be derived from this study is the novel role of TSC2/TSC2 in the maintenance of the nuclear envelope structure and the early mitotic checkpoint mediated by CHFR. Our results suggest that the regulation of nuclear envelope structure is specific to TSC2/TSC2 relative to TSC1/TSC1, which may provide additional explanations for the increased clinical severity associated with TSC2 mutations. 21, 22 Alterations of this structure are commonly associated with human genetic diseases with muscular-related anomalies and, in some cases, accompanied by neurological abnormalities (reviewed in ref. 83 ). In addition, TACCs are critical in interkinetic nuclear migration in neuronal progenitors: concomitant to altered microtubule organization, perturbation of TACCs affects nuclear position and mode of division. 84 These observations may be linked to the putative neuronal migration defect in TSC disease. 85, 86 Interestingly, Tsc1 and Tsc2 have recently been shown to regulate axon formation and growth through the key polarity protein SAD kinase, 87 which also regulates cell cycle checkpoints. 88 The question of whether SAD integrates TACC3 with TSC1/TSC2 in neuronal and/or epithelial differentiation, in addition to regulating CHFR function, may appear as a fundamental issue in the study of TSC pathology.
Finally, the genetic interaction at the early mitotic checkpoint and the molecular and localization-dependent associations observed in cytokinesis suggest a global control of cell division Sigma-Aldrich) inhibitors. Cells were incubated in lysis buffer for 15 min at 4°C and clarified twice by centrifugation at 13,000 xg for 20 min. Protein concentrations in the clarified lysates were determined by the Bradford BioRad Protein Assay. Preclearing was carried out for one hour at 4°C with Protein G Sepharose 4 Fast Flow (GE Healthcare). Immunoprecipitations using 2.5-5 µg of antibodies were performed at 4°C overnight. Samples were then incubated for one hour at 4°C with Protein G Sepharose 4 Fast Flow (GE Healthcare), washed three times with lysis buffer and denatured prior to gel analysis.
Microtubule binding assay. Microtubule binding assays were performed as described previously. 100 Briefly, HEK293 cells were collected by trypsinization and homogenized in PHEM buffer (60 mM PIPES, 25 mM HEPES, 1 mM EGTA, 1 mM Mg(CH 3 COO) 2 pH 6.8) supplemented with protease and phosphatase inhibitor cocktails (Sigma-Aldrich). The homogenate was then clarified by centrifugation at 14,000 xg for 30 min, GTP was added to a final concentration of 1 mM, and taxol or nocodazole was added to a final concentration of 20 µM and 100 µM, respectively. Next, homogenates were incubated for 30 min at room temperature with rotation, layered onto an equal volume of 15% sucrose cushion in PHEM buffer and centrifuged at 14,000 xg for 15 min. The supernatants and cushions were aspirated, the pellets were washed once in PHEM buffer and denatured prior to gel analysis.
Immunofluorescence microscopy. Cells were grown on glass cover slips and fixed with ice-cold methanol for 10 min followed by three washes in PBS. Permeabilization and blocking was performed in 1x PBS, 4% FBS and 0.02% Tween 20 (Sigma-Aldrich). Staining was performed overnight at 4°C in these conditions using appropriate primary antibody dilutions. Next, samples were washed three times with 0.02% Tween 20 in PBS, incubated for 30 min at room temperature with Alexa fluor-conjugated secondary antibodies (Invitrogen), washed three times with 0.02% Tween 20 in PBS, and mounted on 4,6-diamidino-2-phenylindole (DAPI)-containing VECTASHIELD solution (Vector Laboratories). Images were obtained using a SPOT RT Mono-2000 camera (Diagnostic Instruments) or, when indicated, using a Nikon Eclipse TE2000-E system equipped with x40/1.0 or x60/1.4 immersion objectives.
Cell fractionation. Cells were harvested at subconfluent density and washed with PBS. Cell pellets were resuspended in 500 µl of Buffer A (10 mM HEPES-KOH (pH 7.9), 1 mM MgCl 2 , 10 mM KCl, 0.5 mM dithiothreitol) containing protease inhibitor cocktail (Roche Molecular Biochemicals) and 10 mM NaF, and incubated for 10 min on ice. Cell membranes were disrupted by 15 passages through a 23-gauge needle plus 10 passages through a 25-gauge needle. Cells were then centrifuged for 5 min at 228 xg at 4°C. The supernatant (cytoplasmatic fraction) was collected and stored at -20°C and the pellet (nuclear fraction) was resuspended in Buffer B (0.25 M sucrose, 10 mM MgCl 2 , with protease and phosphatase inhibitors), re-homogenized by 10 passages through a 23-gauge needle and centrifuged for 5 min at 1,430 xg in a sucrose cushion (Buffer C: 0.35 M sucrose, 0.5 mM MgCl 2 , and protease and phosphatase inhibitors). The pellets (purified nuclei) were resuspended in STM buffer (250 mM sucrose, 50
Phylogenetic analyses. PSI-BLAST searches 94 were performed against proteins encoded in genomes deposited in Ensembl as of January 2008, using human TACC proteins. Parameters were set to a maximum of five iterations and an e-value threshold of 10 -4 . The phylogenetic pipeline used here is adapted from HuertasCepas et al. 95 Alignments of homologous sets of proteins were performed with MUSCLE 3.6, 96 and trimmed to remove columns with gaps in more than 10% of the sequences, unless the procedure removed more than one third of the positions in the alignment. In such cases the permissible percentage of sequences with gaps was increased automatically until at least two thirds of the initial columns were conserved. Phylogenetic trees were reconstructed using Maximum Likelihood (ML) as implemented in PhyML v2.4.4. 97 We used a discrete gamma-distribution model with four rate categories, in which invariant sites and the gamma shape parameter were estimated from the data. Four different evolutionary models were used (JTT, Dayhoff, VT and BLOSUM62) and the one best fitting the data according to the AIC criterion was selected.
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Cell culture. Spontaneously immortalized Tsc2
+/+ /Tp53 -/-and Tsc2 -/-/Tp53 -/-MEFs were cultured in DMEM, 10% FBS, 2 mM L-glutamine and 100 µM non-essential aa, and using culture plates pre-treated with collagen R2 dissolved at 2 mg/ml in 0.1% acetic acid. Tsc2-deficient ELT3 cells derived from a uterine leiomyoma of Eker rats, 99 were cultured in DMEM-F12 supplemented with 15% FBS, 2 mM L-glutamine and 2 mM sodium pyruvate. hTSC2-reconstituted ELT3 and hTSC1-reconstituted Tsc1 -/-cells were cultured as described previously. 45, 60 Where indicated, cells were arrested in G 2 /M using 5 ng/ml nocodazole or vehicle control (DMSO, Sigma-Aldrich) for 12-24 h.
Co-AP and co-IP assays. TACC3 C-term ORF was transferred into an N-terminal GST-tagged Gateway-compatible vector pDEST-27 (Invitrogen). For co-AP assays, plasmids (1.5 µg) were transfected into HEK293 cells in six-well format using Lipofectamine 2000 (Invitrogen). Next, cells were cultured for 48 h and lysates prepared in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.5% Nonidet P-40, 1 mM EDTA, and protease inhibitor cocktail (Roche Molecular Biochemicals). Lysates were clarified twice by centrifugation at 13,000 xg before purification of protein complexes using glutathione-Sepharose beads (GE Healthcare) for one hour at 4°C. BHK cells were lysed in PD buffer containing 10 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 0.2% Triton X-100 and protease inhibitor cocktail (Roche Molecular Biochemicals). Purified complexes and control lysate samples were resolved in Tris-glycine-SDS PAGE gels, transferred to Invitrolon PVDF membranes (Invitrogen) or Immobilon PVDF (Millipore), and target proteins were identified by detection of HRP-labeled antibody complexes with chemiluminescence using ECL or ECL-Plus western blotting Detection Kit (GE Healthcare) following standard protocols. For co-IP assays, cells were harvested at subconfluent density, washed twice with PBS and lysed in buffer containing 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 0.5% Nonidet P-40, 1 mM EDTA, protease inhibitor cocktail (Roche Molecular Biochemicals) and, in some assays, supplementary phosphatase (10 mM NaF) or proteasome (MG132, DAPI. Tsc1-deficient cells were treated similarly, permeabilized in 0.1% Triton X-100 and 1x PBS for 30 min, blocked in this solution with 3% BSA for 30 min and mounted with GelMount (Biomeda) prior to direct immunofluorescence and counting.
Antibodies. Immunofluorescence and confocal microscopy studies were performed with anti-AURKB (AIM-1 clone 6, BD Transduction Laboratories), anti-pS2448-mTOR (Cell Signaling Technology catalog #2971), anti-NUP62 (clone 53, BD Transduction Laboratories), anti-TACC3 (D-2 and H-300, Santa Cruz Biotechnologies), anti-TSC1 (clone 5C8A12, Zymed, Invitrogen), anti-TSC2 (clone 3G9D9, Zymed, Invitrogen), antipS939-TSC2 (Cell Signaling Technology catalog #3615) and anti-TUBG1 (clone GTU-88, Sigma-Aldrich). Immunoprecipitation assays were performed with anti-TACC3 (N-18, Upstate Biotechnology; H-300, Santa Cruz Biotechnologies), anti-TSC2 (C-20, Santa Cruz Biotechnology; clone 3G9D9, Zymed, Invitrogen), anti-TSC1 (clone 5C8A12, Zymed, Invitrogen) and anti-TUBA (Acris catalog #SM568P). Other antibodies used in this study were anti-ARHGEF2 (aa 41-487), 101 anti-CGN (H-180, Santa Cruz Biotechnologies), anti-CHFR (M01 clone 1H3-A12, Abnova), anti-HA (clone 16B12, BAbCO), anti-CP110 (aa 1-149), anti-LMNA (clone 133A2, Chemicon, Millipore), anti-Rasa1 (clone B4F8, Upstate, Millipore), anti-PLK1 (clone 35-206, Invitrogen) and anti-pT389-S6K (Cell Signaling Technology catalog #9205). Purified negative control IgGs of different species were purchased from Santa Cruz Biotechnologies. Epitope tag antibodies were anti-FLAG M2 (Sigma-Aldrich), anti-GFP (clone JL-8, BD Biosciences), anti-GST (Sigma-Aldrich) and anti-MYC (clone 9E10, SigmaAldrich). Secondary HRP-linked antibodies were purchased from GE Healthcare and fluor-linked antibodies were Alexa 488, 546, 594 and 633 nm, anti-mouse, anti-rabbit or anti-rat (Molecular Probes, Invitrogen).
